These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 8084786)
1. Ulcer-healing drugs and their actions and side-effects. Andrews C Nurs Times; 1994 Aug 17-23; 90(33):38-40. PubMed ID: 8084786 [TBL] [Abstract][Full Text] [Related]
2. Agents with tricyclic structures for treating peptic ulcer disease. Berardi RR; Caplan NB Clin Pharm; 1983; 2(5):425-31. PubMed ID: 6354568 [TBL] [Abstract][Full Text] [Related]
3. Is 1-week treatment for peptic ulcer healing sufficient and safe? García S; Fuentes J; Ducóns JA; Barrera F; Yus C; Gomollón F Rev Esp Enferm Dig; 2000 Jan; 92(1):5-12. PubMed ID: 10749593 [TBL] [Abstract][Full Text] [Related]
4. Your CE topic this month (No. 27). Peptic ulcer disease. Olsen KM; Barton CL J Pract Nurs; 1987 Dec; 37(4):20-7. PubMed ID: 3440944 [No Abstract] [Full Text] [Related]
5. [Effectiveness and safety of lansoprazole in the treatment of peptic ulcer]. Ramón Nogueira J; Esquivel Ayanegui F; Esquivel Rodríguez F; Sáenz V; Santoyo R Rev Gastroenterol Mex; 1996; 61(4):314-9. PubMed ID: 9072782 [TBL] [Abstract][Full Text] [Related]
6. Healing-promoting action of rhinax with dual action on chronic gastric and duodenal ulcers induced by acetic acid in rats. Dhuley JN Hindustan Antibiot Bull; 2003 Feb-2004 Nov; 45-46(1-4):34-40. PubMed ID: 16281827 [TBL] [Abstract][Full Text] [Related]
7. Healing-promoting action of the new histamine H2-receptor antagonist N-ethyl-N'-[3-[3-(piperidinomethyl)phenoxy]propyl]urea with dual action on chronic gastric and duodenal ulcers induced by acetic acid in rats. Sekiguchi H; Hamada K; Aijima H; Taga F; Uchida H; Nishino K Arzneimittelforschung; 1993 Feb; 43(2):139-43. PubMed ID: 8096134 [TBL] [Abstract][Full Text] [Related]
8. [The course of the reparative process in patients with gastric and duodenal peptic ulcers (a clinico-statistical study)]. Grinevich VB; Tkachenko EI; Uspenskiĭ IuP Ter Arkh; 1993; 65(2):13-7. PubMed ID: 9132999 [TBL] [Abstract][Full Text] [Related]
9. [Present position in the prevention and therapy of NSAID-induced ulcers]. Lehmann FS; Beglinger C Schweiz Med Wochenschr; 1999 Jul; 129(29-30):1073-80. PubMed ID: 10464910 [TBL] [Abstract][Full Text] [Related]
10. [Bismuth preparations in the treatment of patients with gastric and duodenal ulcer disease]. Maev IV; Samsonov AA; Golubev NN Klin Med (Mosk); 2008; 86(9):57-63. PubMed ID: 19048841 [TBL] [Abstract][Full Text] [Related]
11. Does smoking predispose to peptic ulcer relapse after eradication of Helicobacter pylori? Chan FK; Sung JJ; Lee YT; Leung WK; Chan LY; Yung MY; Chung SC Am J Gastroenterol; 1997 Mar; 92(3):442-5. PubMed ID: 9068465 [TBL] [Abstract][Full Text] [Related]
12. Some aspects of the critical evaluation of peptic ulcer therapy in patients. Mózsik G; Bertelli A; Deak G; Nagy L; Patty I; Simon L; Tárnok F; Jávor T Int J Clin Pharmacol Res; 1985; 5(6):447-55. PubMed ID: 4093220 [TBL] [Abstract][Full Text] [Related]
13. The influence of the eradication of Helicobacter pylori on gastric ghrelin, appetite, and body mass index in patients with peptic ulcer disease. Jang EJ; Park SW; Park JS; Park SJ; Hahm KB; Paik SY; Sin MK; Lee ES; Oh SW; Park CY; Baik HW J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S278-85. PubMed ID: 19120912 [TBL] [Abstract][Full Text] [Related]
14. [Formation of a gastric bezoar following upper digestive hemorrhage caused by a medically-treated ulcer]. Gentile F; Tempesti M; Mancini P J Radiol; 1984; 65(6-7):475-6. PubMed ID: 6092631 [TBL] [Abstract][Full Text] [Related]
15. Anti-Helicobacter pylori treatment in bleeding ulcers: randomized controlled trial comparing 2-day versus 7-day bismuth quadruple therapy. Kung NN; Sung JJ; Yuen NW; Ng PW; Wong KC; Chung EC; Lim BH; Choi CH; Li TH; Ma HC; Kwok SP Am J Gastroenterol; 1997 Mar; 92(3):438-41. PubMed ID: 9068464 [TBL] [Abstract][Full Text] [Related]
16. Variations in the risk of gastrointestinal hemorrhage with non-steroidal anti-inflammatory drugs and localization of lesions. Pulanić R; Dubravcić D; Ostojić-Pulanić B; Vrhovac B Acta Med Croatica; 1998; 52(2):91-8. PubMed ID: 9682495 [TBL] [Abstract][Full Text] [Related]
17. [Pharmacotherapy of non-associated with Helicobacter pylori ulcer]. Grinevich VB; Uspenskiĭ IuP; Shabanova GZh; Sablin OA; Shcherbina NN Klin Med (Mosk); 2002; 80(10):44-6. PubMed ID: 12471838 [TBL] [Abstract][Full Text] [Related]
18. Treatment of the gastric stump ulcer: an open study with five drugs. Janke A; Stasiewicz J; Namiot Z; Szalaj W Hepatogastroenterology; 2000; 47(34):1195-8. PubMed ID: 11020913 [TBL] [Abstract][Full Text] [Related]
19. Present and future treatment of peptic ulcer and potential role of DE-NOL. Scand J Gastroenterol Suppl; 1982; 80():49-57. PubMed ID: 6761852 [No Abstract] [Full Text] [Related]
20. [Specific IgE in the gastric and duodenal mucosa. An epiphenomenon or pathogenetic mechanism of some forms of "peptic" ulcer?]. De Lazzari F; Venturi C; Fregona I; Galliani EA; Bortolami M; Violato D; Floreani AR; Plebani M; Naccarato R Minerva Gastroenterol Dietol; 1994 Mar; 40(1):1-9. PubMed ID: 8204699 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]